SEEG-Guided DBS for OCD
NCT: NCT05623306 · RECRUITING
Brief Summary
This is a multi-site, double-blinded, randomized, crossover study design for SEEG-guided 4-lead DBS for treatment-refractory OCD, followed by open-label stimulation for an additional 6 months. The study will be conducted in 3 stages: Stage 1 will consist of SEEG brain mapping and optimization of stimulation parameters. Stage 2 will consist of DBS surgery and further optimization of stimulation parameters. Stage 3 will be randomized, crossover treatment, followed by open-label treatment.
Frequently Asked Questions
What is SEEG-Guided DBS for OCD?
SEEG-Guided DBS for OCD is a clinical trial registered under NCT05623306. Current status: RECRUITING.
What is the status of NCT05623306?
The current status of NCT05623306 (SEEG-Guided DBS for OCD) is: RECRUITING.
When did SEEG-Guided DBS for OCD start?
SEEG-Guided DBS for OCD started on 2023-04-13.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.